Reduced contrast sensitivity function and outer retina thickness in convalescent Vogt-Koyanagi-Harada disease

Sakata VM, Da Silva FT, Hirata CE, De Carvalho JF, Yamamoto JH. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev. 2014;13:550–555.

Article  CAS  PubMed  Google Scholar 

O’keefe GA, Rao NA. Vogt-Koyanagi-Harada disease. Surv Ophthalmol. 2017;62:1–25.

Article  PubMed  Google Scholar 

Yang P, Zhong Z, Du L, Li F, Chen Z, Zhu Y, et al. Prevalence and clinical features of systemic diseases in Chinese patients with uveitis. Br J Ophthalmol. 2021;105:75–82.

Article  PubMed  Google Scholar 

Lee EK, Lee SY, Yu HG. A clinical grading system based on ultra-wide field retinal imaging for sunset glow fundus in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol. 2015;253:359–368.

Article  PubMed  Google Scholar 

Abu El-Asrar AM, Al Mudhaiyan T, Al Najashi AA, Hemachandran S, Hariz R, Mousa A, et al. Chronic recurrent Vogt-Koyanagi-Harada disease and development of ‘sunset glow fundus’ predict worse retinal sensitivity. Ocul Immunol Inflamm. 2017;25:475–485.

Article  CAS  PubMed  Google Scholar 

Chee SP, Luu CD, Cheng CL, Lim WK, Jap A. Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol. 2005;243:785–790.

Article  PubMed  Google Scholar 

Yang P, Zhang Z, Zhou H, Li B, Huang X, Gao Y, et al. Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China. Curr Eye Res. 2009;30:943–948.

Article  Google Scholar 

Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265–292.

Article  CAS  PubMed  Google Scholar 

Abu El-Asrar AM, Al Tamimi M, Hemachandran S, Al-Mezaine HS, Al-Muammar A, Kangave D. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91:e486–493.

Article  CAS  PubMed  Google Scholar 

Keino H, Goto H, Usui M. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol. 2002;240:878–882.

Article  PubMed  Google Scholar 

Yang P, Ye Z, Du L, Zhou Q, Qi J, Liang L, et al. Novel treatment regimen of Vogt-Koyanagi-Harada disease with a reduced dose of corticosteroids combined with immunosuppressive agents. Curr Eye Res. 2018;43:254–261.

Article  CAS  PubMed  Google Scholar 

Murata T, Sako N, Takayama K, Harimoto K, Kanda K, Herbort CP Jr, et al. Identification of underlying inflammation in Vogt-Koyanagi-Harada disease with sunset glow fundus by multiple analyses. J Ophthalmol. 2019;2019:3853794.

Article  PubMed  PubMed Central  Google Scholar 

Yang P, Sun M, Liu X, Zhou H, Fang W, Wang L, et al. Alterations of color vision and central visual field in patients with Vogt-Koyanagi-Harada syndrome. J Ophthalmic Inflamm Infect. 2012;2:75–79.

Article  PubMed  PubMed Central  Google Scholar 

Wai KM, Vingopoulos F, Garg I, Kasetty M, Silverman RF, Katz R, et al. Contrast sensitivity function in patients with macular disease and good visual acuity. Br J Ophthalmol. 2022;106:839–844.

Owsley C, Sloane ME. Contrast sensitivity, acuity, and the perception of ‘real-world’ targets. Br J Ophthalmol. 1987;71:791–796.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang P, Fang W, Wang L, Wen F, Wu W, Kijlstra A, et al. Study of macular function by multifocal electroretinography in patients with Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 2008;146:767–771.

Article  PubMed  Google Scholar 

Sakata VM, Lavezzo MM, Da Silva FT, Rodriguez EEC, Morita C, Abdallah SF, et al. Full-field electroretinogram behavior in Vogt-Koyanagi-Harada disease: a 24-month longitudinal study in patients from acute onset evaluated with multimodal analysis. Graefes Arch Clin Exp Ophthalmol. 2019;257:2285–2295.

Article  CAS  PubMed  Google Scholar 

Wood RL, Wood JM. The role of contrast sensitivity charts and contrast letter charts in clinical practice. Clin Exp Optom. 2010;78:43–57.

Joltikov KA, De Castro VM, Davila JR, Anand R, Khan SM, Farbman N, et al. Multidimensional functional and structural evaluation reveals neuroretinal impairment in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2017;58:BIO277–BIO290.

Article  PubMed  PubMed Central  Google Scholar 

Raming K, Gliem M, Charbel Issa P, Birtel J, Herrmann P, Holz FG, et al. Visual dysfunction and structural correlates in Sorsby Fundus Dystrophy. Am J Ophthalmol. 2022;234:274-284.

Tu Y, Jin H, Xu M, Liu W, Hu X, Wang M, et al. Reduced contrast sensitivity function correlated with superficial retinal capillary plexus impairment in early stage of dysthyroid optic neuropathy. Eye Vis. 2023;10:11.

Article  Google Scholar 

Oner O, Akca Bayar S, Oto S, Gokmen O, Tekindal MA. Contrast sensitivity in microtropic and anisometropic eyes of successfully treated amblyopes. Turk J Ophthalmol. 2017;47:74–79.

Article  PubMed  PubMed Central  Google Scholar 

Souto FMS, Missaka R, Lavezzo MM, Nobrega PFC, Sakata VM, Oyamada MK, et al. Quality of Life (QoL) in Non-Acute Vogt-Koyanagi-Harada Disease (VKHD) at Two Time Points 24 Months Apart. Ocul Immunol Inflamm. 2024;32:384–390.

Wang J, Cui Y, Vingopoulos F, Kasetty M, Silverman RF, Katz R, et al. Disorganisation of retinal inner layers is associated with reduced contrast sensitivity in retinal vein occlusion. Br J Ophthalmol. 2022;106:241–245.

Fatehi N, Nowroozizadeh S, Henry S, Coleman AL, Caprioli J, Nouri-Mahdavi K. Association of structural and functional measures with contrast sensitivity in glaucoma. Am J Ophthalmol. 2017;178:129–139.

Article  PubMed  PubMed Central  Google Scholar 

Joltikov KA, Sesi CA, De Castro VM, Davila JR, Anand R, Khan SM, et al. Disorganization of retinal inner layers (DRIL) and neuroretinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2018;59:5481–5486.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao NA, Wu GS. Free radical mediated photoreceptor damage in uveitis. Prog Retin Eye Res. 2000;19:41–68.

Article  CAS  PubMed  Google Scholar 

Zhou M, Jiang C, Gu R, Sun Z, Huynh N, Chang Q. Correlation between retinal changes and visual function in late-stage Vogt-Koyanagi-Harada disease: an optical coherence tomography study. J Ophthalmol. 2015;2015:916485.

Article  PubMed  PubMed Central  Google Scholar 

Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, et al. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250:1089–1095.

Article  PubMed  Google Scholar 

Takahashi H, Takase H, Ishizuka A, Miyanaga M, Kawaguchi T, Ohno-Matsui K, et al. Choroidal thickness in convalescent Vogt-Koyanagi-Harada disease. Retina. 2014;34:775–780.

Article  PubMed  Google Scholar 

Zhou M, Gu RP, Sun Z, Jiang CH, Chang Q, Xu GZ. Differences in photoreceptor recovery among patients and between different parts of the posterior pole in Vogt-Koyanagi-Harada disease. Eye. 2018;32:572–578.

Article  CAS  PubMed  Google Scholar 

Jap A, Chee SP. The role of enhanced depth imaging optical coherence tomography in chronic Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2017;101:186–189.

Article  PubMed  Google Scholar 

Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652.

Article  CAS  PubMed  Google Scholar 

Yang P, Zhong Y, Du L, Chi W, Chen L, Zhang R, et al. Development and evaluation of diagnostic criteria for Vogt-Koyanagi-Harada disease. JAMA Ophthalmol. 2018;136:1025–1031.

Article  PubMed  PubMed Central  Google Scholar 

Nakayama M, Keino H, Watanabe T, Okada AA. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids. Br J Ophthalmol. 2019;103:274–278.

Article  PubMed  Google Scholar 

Hirooka K, Saito W, Namba K, Mizuuchi K, Iwata D, Hashimoto Y, et al. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids. PLoS ONE 2017;12:e0172612.

Article  PubMed  PubMed Central 

Comments (0)

No login
gif